We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
276
DELISTED
NEVRO CORP.
NVRO
| $61M | 0.08% |
583,908
+412,258
| +240% | +$37.2M |
|
277
KKR & Co
KKR
$89.2B
| $60.4M | 0.08% |
4,232,950
+117,975
| +3% | +$1.67M |
|
278
Bausch Health
BHC
$1.65B
| $59.3M | 0.07% |
2,415,515
+1,572,463
| +187% | +$40.7M |
|
279
NVIDIA
NVDA
$5.01T
| $59M | 0.07% |
34,425,040
-110,807,920
| -76% | -$164M |
|
|
EEQ
280
DELISTED
Enbridge Energy Management Llc
EEQ
| $58.6M | 0.07% |
2,840,981
-31,780
| -1% | -$604K |
|
281
Repligen
RGEN
$7.44B
| $58.5M | 0.07% |
1,939,285
+45,661
| +2% | +$1.38M |
|
282
ConocoPhillips
COP
$147B
| $58.1M | 0.07% |
1,336,047
-180,943
| -12% | -$7.52M |
|
283
Robert Half
RHI
$3.61B
| $57.2M | 0.07% |
1,510,170
+182,350
| +14% | +$6.95M |
|
284
Monolithic Power Systems
MPWR
$65.5B
| $57M | 0.07% |
707,752
-109,538
| -13% | -$8.09M |
|
285
MKS Inc
MKSI
$22.2B
| $56.5M | 0.07% |
1,135,933
+320,372
| +39% | +$15.1M |
|
286
Regeneron Pharmaceuticals
REGN
$68.8B
| $56.4M | 0.07% |
140,395
+26,974
| +24% | +$10.8M |
|
287
HubSpot
HUBS
$10.5B
| $56.2M | 0.07% |
975,683
+64,200
| +7% | +$3.48M |
|
288
Bright Horizons
BFAM
$3.99B
| $56.2M | 0.07% |
840,207
-182,240
| -18% | -$12.3M |
|
289
Nasdaq
NDAQ
$51.5B
| $55.7M | 0.07% |
2,474,448
+1,107,753
| +81% | +$25.6M |
|
290
Pool Corp
POOL
$6.7B
| $55.2M | 0.07% |
584,090
+189,662
| +48% | +$18.6M |
|
291
Stanley Black & Decker
SWK
$14.2B
| $55M | 0.07% |
447,123
-79,212
| -15% | -$9.56M |
|
292
CVS Health
CVS
$137B
| $54.9M | 0.07% |
617,155
-1,184,562
| -66% | -$112M |
|
|
CAA
293
DELISTED
CalAtlantic Group, Inc.
CAA
| $54.7M | 0.07% |
1,636,700
+31,541
| +2% | +$1.16M |
|
294
Acadia Realty Trust
AKR
$2.99B
| $54.6M | 0.07% |
1,505,810
+102,291
| +7% | +$3.74M |
|
295
Aon
AON
$77.3B
| $54.5M | 0.07% |
484,215
-10,234
| -2% | -$1.13M |
|
|
TAHO
296
DELISTED
Tahoe Resources Inc
TAHO
| $53.9M | 0.07% |
4,198,210
+439,400
| +12% | +$6.51M |
|
297
Eli Lilly
LLY
$1.07T
| $53.7M | 0.07% |
669,365
+35,199
| +6% | +$2.82M |
|
298
Global Partners
GLP
$1.64B
| $53.7M | 0.07% |
3,326,441
+367,204
| +12% | +$5.38M |
|
299
Norwegian Cruise Line
NCLH
$8.89B
| $53.5M | 0.07% |
1,417,800
+1,152,581
| +435% | +$44.7M |
|
300
Sally Beauty Holdings
SBH
$1.4B
| $53.4M | 0.07% |
2,080,255
+71,778
| +4% | +$2.01M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.